Celldex Therapeutics, Inc.

CLDX

$31.10

Name : Celldex Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $2,442,268,672.00

EPSttm : -4.35

Celldex Therapeutics, Inc.

$31.10

1.21%

$0.38

CLDX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

11.79

Margin Of Safety %

Put/Call OI Ratio

0.77

EPS Next Q Diff

-0.07

EPS Last/This Y

-0.22

EPS This/Next Y

-0.11

Price

31.09

Target Price

62.5

Analyst Recom

1.2

Performance Q

-11.8

Upside

-282.3%

Beta

0.89

Ticker: CLDX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	CLDX	39.13	1.52	4.27	11718
2026-08-31	CLDX	39.61	1.53	2.55	11827
2026-09-02	CLDX	39.46	1.61	3.84	12315
2026-09-03	CLDX	39.36	1.63	7.30	12484
2026-09-04	CLDX	39.66	1.63	2.32	12634
2026-09-08	CLDX	39.14	1.62	7.75	13304
2026-09-09	CLDX	38.8	1.68	10.06	13717
2026-09-10	CLDX	38.08	1.67	0.04	13674
2026-09-11	CLDX	36.88	1.48	0.52	14374
2026-09-14	CLDX	39.22	1.37	0.21	15453
2026-09-15	CLDX	38.47	0.88	0.08	21628
2026-09-16	CLDX	38.71	0.85	0.56	22135
2026-09-17	CLDX	38.97	0.83	70.87	22763
2026-09-18	CLDX	38.23	1.07	0.30	25915
2026-09-21	CLDX	37.85	1.06	0.25	25475
2026-09-22	CLDX	33.51	1.05	0.78	25682
2026-09-23	CLDX	31.66	0.87	0.53	30964
2026-09-24	CLDX	31.52	0.82	0.04	30193
2026-09-25	CLDX	31.11	0.77	0.30	31248
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	CLDX	39.44	0.5	-9.3	-4.11
2026-08-31	CLDX	39.62	0.5	-26.5	-4.11
2026-09-01	CLDX	39.24	0.5	-16.2	-4.11
2026-09-02	CLDX	39.48	0.5	-85.5	-4.11
2026-09-03	CLDX	39.38	0.5	-81.0	-4.11
2026-09-04	CLDX	39.68	0.5	-86.7	-4.11
2026-09-08	CLDX	39.13	-0.1	-75.0	-4.12
2026-09-09	CLDX	38.80	-0.1	-79.1	-4.12
2026-09-10	CLDX	38.08	-0.1	-73.3	-4.12
2026-09-11	CLDX	36.89	-0.1	-65.7	-4.12
2026-09-14	CLDX	39.16	-0.1	-115.4	-4.12
2026-09-15	CLDX	38.44	-0.1	-72.0	-4.12
2026-09-16	CLDX	38.44	-0.1	-72.0	-4.12
2026-09-17	CLDX	38.99	-0.1	-86.3	-4.12
2026-09-18	CLDX	38.22	-0.1	-71.7	-4.12
2026-09-21	CLDX	37.88	-0.1	-77.5	-4.12
2026-09-22	CLDX	33.49	-0.1	-20.0	-4.12
2026-09-23	CLDX	31.12	-0.1	-42.3	-4.12
2026-09-24	CLDX	31.47	-0.1	-88.6	-4.12
2026-09-25	CLDX	31.09	-0.1	-75.4	-4.12
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	CLDX	0.00	19.10	9.97
2026-08-31	CLDX	0.00	19.23	9.97
2026-09-01	CLDX	0.00	19.23	9.97
2026-09-02	CLDX	0.00	19.23	9.97
2026-09-03	CLDX	0.00	19.23	9.97
2026-09-04	CLDX	0.00	19.23	9.97
2026-09-08	CLDX	0.00	19.55	9.97
2026-09-09	CLDX	0.00	19.55	9.97
2026-09-10	CLDX	0.00	19.55	9.97
2026-09-11	CLDX	0.00	19.55	11.38
2026-09-14	CLDX	0.00	19.58	11.38
2026-09-15	CLDX	0.00	19.58	11.38
2026-09-16	CLDX	0.00	19.58	11.38
2026-09-17	CLDX	0.00	19.58	11.38
2026-09-18	CLDX	0.00	19.58	11.38
2026-09-21	CLDX	0.00	19.58	11.38
2026-09-23	CLDX	0.00	19.58	11.38
2026-09-24	CLDX	0.00	19.58	11.38
2026-09-25	CLDX	0.00	19.58	11.79
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.94

Avg. EPS Est. Current Quarter

-1.01

Avg. EPS Est. Next Quarter

-1.01

Insider Transactions

Institutional Transactions

19.58

Beta

0.89

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

45.6

Max Drawdown 5-Year %

-73.1

Target Price

62.5

P/E

Forward P/E

PEG

P/S

15264.18

P/B

3.42

P/Free Cash Flow

EPS

-4.36

Average EPS Est. Cur. Y

-4.12

EPS Next Y. (Est.)

-4.24

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-190220.89

Relative Volume

1.62

Return on Equity vs Sector %

-68.3

Return on Equity vs Industry %

-48.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

-75.4

◆ CLDX Healthcare

$31.10

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

13/25

Volume

3/15

Valuation

12/20

TP/AR

3/10

Options

4/10

RSI

24.9

Range 1M

4.4%

Sup Dist

0.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

5/30

Estimates

2/20

Inst/Vol

9/15

Options

8/10

EPS Yr

-6%

EPS NY

-2.1%

52W%

38.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +101% upside

Quality

2/30

Valuation

15/30

Growth

3/25

Stability

9/10

LT Trend

3/5

Upside

+101%

Quality

CLDX — P/E HistoricalBiotechnology

Celldex Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 198

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.

CLDX

Latest News

—

Caricamento notizie per CLDX…

stock quote shares CLDX – Celldex Therapeutics, Inc. Stock Price stock today

news today CLDX – Celldex Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CLDX – Celldex Therapeutics, Inc. yahoo finance google finance

stock history CLDX – Celldex Therapeutics, Inc. invest stock market

stock prices CLDX premarket after hours

ticker CLDX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CLDX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y